Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Rev Neurosci ; 8(9): 673-86, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17704810

ABSTRACT

In many areas of the vertebrate brain, such as the cerebral and cerebellar cortices, neural circuits rely on inhibition mediated by GABA (gamma-aminobutyric acid) to shape the spatiotemporal patterns of electrical signalling. The richness and subtlety of inhibition are achieved by diverse classes of interneurons that are endowed with distinct physiological properties. In addition, the axons of interneurons display highly characteristic and class-specific geometry and innervation patterns, and thereby distribute their output to discrete spatial domains, cell types and subcellular compartments in neural networks. The cellular and molecular mechanisms that specify and modify inhibitory innervation patterns are only just beginning to be understood.


Subject(s)
Cerebellar Cortex/physiology , Cerebral Cortex/physiology , gamma-Aminobutyric Acid/physiology , Animals , Cerebellar Cortex/cytology , Cerebral Cortex/cytology , Humans , Interneurons/physiology , Models, Biological , Nerve Net/cytology , Nerve Net/physiology , Neural Inhibition/physiology , Synapses/physiology
2.
Clin Genet ; 72(1): 1-8, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17594392

ABSTRACT

GABAergic interneurons powerfully control the function of cortical networks. In addition, they strongly regulate cortical development by modulating several cellular processes such as neuronal proliferation, migration, differentiation and connectivity. Not surprisingly, aberrant development of GABAergic circuits has been implicated in many neurodevelopmental disorders including schizophrenia, autism and Tourette's syndrome. Unfortunately, efforts directed towards the comprehension of the mechanisms regulating GABAergic circuits formation and function have been impaired by the strikingly heterogeneity, both at the morphological and functional level, of GABAergic interneurons. Recent technical advances, including the improvement of interneurons-specific labelling techniques, have started to reveal the basic principles underlying this process. This review summarizes recent findings on the mechanisms underlying the construction of GABAergic circuits in the cortex, with a particular focus on potential implications for brain diseases with neurodevelopmental origin.


Subject(s)
Brain Diseases/etiology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , gamma-Aminobutyric Acid/metabolism , Autistic Disorder/etiology , Brain Diseases/metabolism , Humans , Interneurons/metabolism , Nerve Net/growth & development , Nerve Net/metabolism , Schizophrenia/etiology , Tourette Syndrome/etiology
3.
Science ; 292(5525): 2337-40, 2001 Jun 22.
Article in English | MEDLINE | ID: mdl-11423664

ABSTRACT

Experience-dependent plasticity in the developing visual cortex depends on electrical activity and molecular signals involved in stabilization or removal of inputs. Extracellular signal-regulated kinase 1,2 (also called p42/44 mitogen-activated protein kinase) activation in the cortex is regulated by both factors. We show that two different inhibitors of the ERK pathway suppress the induction of two forms of long-term potentiation (LTP) in rat cortical slices and that their intracortical administration to monocularly deprived rats prevents the shift in ocular dominance towards the nondeprived eye. These results demonstrate that the ERK pathway is necessary for experience-dependent plasticity and for LTP of synaptic transmission in the developing visual cortex.


Subject(s)
Long-Term Potentiation , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinases/metabolism , Visual Cortex/physiology , Animals , Butadienes/pharmacology , Enzyme Activation , Enzyme Inhibitors/pharmacology , Evoked Potentials, Visual/drug effects , Flavonoids/pharmacology , In Vitro Techniques , Long-Term Potentiation/drug effects , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Nitriles/pharmacology , Phosphorylation , Photic Stimulation , Rats , Vision, Ocular/drug effects , Visual Cortex/drug effects , Visual Perception/drug effects
4.
Eur J Neurosci ; 13(4): 833-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11207819

ABSTRACT

We have explored whether overexpression of the bcl-2 gene 'per se' can promote regeneration of retinal ganglion cells (RGCs) after optic nerve axotomy in developing transgenic mice. We have used newborn mice (postnatal day 5) because at this age the central nervous system environment is more permissive for regeneration than in adults, thus, maximizing the probability to detect a regeneration-promoting role of bcl-2. Thirty days postsurgery we found that in mice overexpressing bcl-2, a high proportion of retinal ganglion cells survived and also that some fibers in the proximal stump of the optic nerve were preserved. However, the optic nerve of transgenic mice does not show signs of regeneration. On the contrary, in the presence of Schwann cell transplants, there are signs of fiber regrowth. Indeed, many axonal terminals cross the crush site and reach the chiasm in both wild type and transgenic mice nerves. These results suggest that bcl-2 overexpression is not sufficient 'per se' to increase the regenerative potentiality of axotomized RGCs.


Subject(s)
Eye Proteins/physiology , Genes, bcl-2 , Nerve Regeneration/physiology , Optic Nerve Injuries/physiopathology , Optic Nerve/physiology , Proto-Oncogene Proteins c-bcl-2/physiology , Retinal Ganglion Cells/physiology , Animals , Animals, Newborn , Eye Proteins/biosynthesis , Female , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Crush , Optic Chiasm/pathology , Optic Nerve Injuries/therapy , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Recombinant Fusion Proteins/physiology , Retinal Ganglion Cells/pathology , Schwann Cells/physiology , Schwann Cells/transplantation
SELECTION OF CITATIONS
SEARCH DETAIL
...